The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform.
<h4>Background</h4>Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6-7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses to addre...
Guardado en:
Autores principales: | Brittany J Maguire, Prabin Dahal, Sumayyah Rashan, Roland Ngu, Anca Boon, Colin Forsyth, Nathalie Strub-Wourgaft, Eric Chatelain, Fabiana Barreira, Sergio Sosa-Estani, Philippe J Guérin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dcd21cb307b9408ea2efdc4b2c2c13ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans.
por: Prabin Dahal, et al.
Publicado: (2021) -
Chemical characterization of Saudi propolis and its antiparasitic and anticancer properties
por: Samyah Alanazi, et al.
Publicado: (2021) -
Arylmethylamino steroids as antiparasitic agents
por: Reimar Krieg, et al.
Publicado: (2017) -
Insights of antiparasitic activity of sodium diethyldithiocarbamate against different strains of Trypanosoma cruzi
por: Johny Wysllas de Freitas Oliveira, et al.
Publicado: (2021) -
Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light
por: Allahverdiyev AM, et al.
Publicado: (2011)